Evidence map›Paper›PMID 34945100›Full record

ArticleJournal of clinical medicine2021

Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis.

Katarzyna Winter, Monika Dzieniecka, Janusz Strzelczyk, Małgorzata Wągrowska-Danilewicz, Marian Danilewicz, Ewa Małecka-Wojciesko

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Katarzyna WinterClinical Department of General and Oncological Gastroenterology, University Clinical Hospital No. 1, 90-153 Lodz, Poland.ORCID 0000-0001-6631-166X
Monika DzienieckaSykehuset Innlandet HF, 2618 Lillehammer, Norway.ORCID 0000-0003-4223-043X
Janusz StrzelczykDepartment of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Małgorzata Wągrowska-DanilewiczDepartment of Nephropathology, Division of Morphometry, Medical University of Lodz, 90-153 Lodz, Poland.
Marian DanilewiczDepartment of Nephropathology, Division of Morphometry, Medical University of Lodz, 90-153 Lodz, Poland.
Ewa Małecka-WojcieskoClinical Department of General and Oncological Gastroenterology, University Clinical Hospital No. 1, 90-153 Lodz, Poland.ORCID 0000-0002-1825-1807
Medical University of Lodz · PLInnlandet Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimFibrosis is observed both in pancreatic cancer (PDAC) and chronic pancreatitis (CP). The main cells involved in fibrosis are pancreatic stellate cells (PSCs), which activate alpha smooth muscle actin (αSMA), which is considered to be the best-known fibrosis marker. The aim of the study was to evaluate the expression of the αSMA in patients with PDAC and CP as the possible differentiation marker.

methodsWe enrolled 114 patients undergoing pancreatic resection: 83 with PDAC and 31 with CP. Normal fragments of resected specimen from 21 patients represented the control tissue. The immunoexpressions of αSMA were detected in tissue specimens with immunohistochemistry (Abcam antibodies, GB).

resultsMean cytoplasmatic expression of αSMA protein in PDAC stromal cells was significantly higher compared to CP: 2.42 ± 0.37 vs 1.95 ± 0.45 (

conclusionsPresented findings confirm the significant role of fibrosis in both PDAC and CP; however, they do not confirm the role of αSMA as a marker of differentiation.

Indexed as

chronic pancreatitispancreatic ductal adenocarcinomapancreatic fibrosispancreatic stellate cellsαSMA

Identifiers

PMID34945100
PMCPMC8707555
OpenAlexW4226208912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.